Home
Search

Memphasys weighs into multi-million dollar equine industry

Headshot of Matt Birney
Matt BirneySponsored
Premium

Memphasys has successfully collected data from approximately 240 horse inseminations to test its novel “SAMSON” stallion fertility diagnostic device that may cut sperm quality diagnosis times down to a rapid 15 minutes. SAMSON measures the quality of semen and predicts the likelihood of the semen achieving a pregnancy. The company says there are no other such devices on the market and horse owners must wait 14 days for an ultrasound to check if an insemination was successful

The field trial data collection was undertaken in New South Wales by University of Newcastle researchers. Data from the approximately 240 mare inseminations was collected from two NSW based equine studs during the horse breeding season in October and November 2021.

Premium

Subscribers with digital access can view this article.

Already a subscriber?

Enjoy exclusive member discounts, giveaways and competitions with our subscriber rewards program.